| Symbol |
Name |
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
ALB
|
albumin
|
|
APOA1
|
apolipoprotein A-I
|
|
APOB
|
apolipoprotein B
|
|
APOC3
|
apolipoprotein C-III
|
|
APOL1
|
apolipoprotein L, 1
|
|
C3
|
complement component 3
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CD19
|
CD19 molecule
|
|
CFH
|
complement factor H
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FOSL1
|
FOS-like antigen 1
|
|
GAA
|
glucosidase, alpha; acid
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GDF15
|
growth differentiation factor 15
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5
|
|
HPGDS
|
hematopoietic prostaglandin D synthase
|
|
HPSE
|
heparanase
|
|
IL10
|
interleukin 10
|
|
IL13
|
interleukin 13
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
LTA
|
lymphotoxin alpha
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUC3A
|
mucin 3A, cell surface associated
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
OGA
|
O-GlcNAcase
|
|
PLA2G12B
|
phospholipase A2, group XIIB
|
|
PLA2G1B
|
phospholipase A2, group IB (pancreas)
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLA2R1
|
phospholipase A2 receptor 1, 180kDa
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLB1
|
phospholipase B1
|
|
PODXL
|
podocalyxin-like
|
|
PPP3R1
|
protein phosphatase 3, regulatory subunit B, alpha
|
|
PRAP1
|
proline-rich acidic protein 1
|
|
RABEP2
|
rabaptin, RAB GTPase binding effector protein 2
|
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5
|
|
RBM45
|
RNA binding motif protein 45
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SNRPN
|
small nuclear ribonucleoprotein polypeptide N
|
|
SNURF
|
SNRPN upstream reading frame
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SPP1
|
secreted phosphoprotein 1
|
|
STMN1
|
stathmin 1
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THSD7A
|
thrombospondin, type I, domain containing 7A
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIP
|
vasoactive intestinal peptide
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
WT1
|
Wilms tumor 1
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
